The aim of identification of patients with high risk of deep venous thrombosis is a selective and more efficiency prophylaxis. Deficiencies of coagulation inhibiting and fibrinolytic proteins are implicated in less than 10% of patients. However there are several clinical situations with an increased risk of thrombosis. Thus the characterization of blood abnormalities as screening tests for the diagnosis of patients at risk is an important goal.